Navigation Links
Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics' Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
Date:12/10/2007

- Company Plans to Initiate Phase IIa Study of NGX426 in Acute Migraine in

First Half of 2008 -

LA JOLLA, Calif., Dec. 10 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today reported pharmacokinetic data obtained in a Phase I maximum tolerated dose clinical trial of NGX426, the oral prodrug of tezampanel, show that the area under the curve (AUC), which represents the total amount of drug absorbed by the body, of a single, 80 mg, oral dose of NGX426 is comparable to the AUC of a single, 40 mg, subcutaneous dose of tezampanel.

With the recently demonstrated efficacy of 40 mg of tezampanel in a Phase IIb clinical trial in acute migraine, the comparable AUCs suggest that NGX426 also may be effective in treating acute migraine headache. TorreyPines Therapeutics plans to initiate a Phase IIa study of NGX426 in acute migraine in the first half of 2008.

"These findings with the oral form of tezampanel are very encouraging, especially when looked at in conjunction with the data from our evaluation of the subcutaneous form," said Neil Kurtz, M.D., President and Chief Executive Officer of TorreyPines Therapeutics. "These data fully support the continued development of NGX426, which, as an oral prodrug, can provide an additional route of administration for tezampanel to acute migraine sufferers."

Initiated earlier this year, this double-blind, placebo-controlled trial enrolled normal healthy adult volunteers in sequential, dose-escalating cohorts. The Phase I data show that single, oral doses of NGX426 from 40 mg to 90 mg are safe and well-tolerated. TorreyPines Therapeutics is amending the Phase I clinical trial protocol to extend the dosing range beyond 90 m
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
2. PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
3. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
4. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
5. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
6. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... May 22, 2013   Life Line Screening ... announced today the creation of a unique partnership with ... MCM is a population health management organization. ... list of clients. These important expanded services will help ... earlier. Effective prevention reduces cost of care when individuals ...
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013 /PRNewswire/ ... creation firm focused on healthcare and sustainability, today ... as a Senior Partner. In this ... support to portfolio companies. In addition ... portfolio, Mr. Bancel also serves as President and ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... N.J., Jan. 3, 2012  Ikaria, Inc., a critical care ... critically ill patients in the hospital and ICU settings, ... program, the PRESERVATION I clinical trial, for its Bioabsorbable ... commenced in Australia, and will be followed in Europe.  ...
... 3, 2012 Reportlinker.com announces that a ... its catalogue: Transdermal Drug ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal drug ...
Cached Medicine Technology:Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 2Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 3Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11
(Date:5/23/2013)... 23, 2013 Great defined abs are the ... everyone strives to achieve in the gym yet so many ... not make this goal become a reality. Great abdominal muscles ... often time overlooked. Scott Tischler of Tischler Brothers Fitness explains ... achieve the goal of great abs. , 1.    Go to bed ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Footwear etc. ... Dansko Vista Collection of sandals containing cork footbeds. Known ... has had consistently good sales for many years, and with ... spring and summer. , Dansko Shoes and ... the Vista Collection is no exception. Containing leather and patent ...
(Date:5/23/2013)... Shirataki noodles are growing in ... a diet strategy. These noodles are originally from Japan ... When losing weight, diet and exercise are the two ... dieters not only research shirataki noodles but offers tons ... buy them. Shirataki noodles are very healthy ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global ... small number of players accounting for a major proportion of ... growth rate between 2006 and 2012, possibly due to the ... markets, especially in the US. , GBI Research estimates ... billion in 2012, having grown in size at a CAGR ...
(Date:5/22/2013)... 2013 Catalyst Exhibits, Inc., an award-winning ... feature to its website that allows visitors to ... through an immersive, 360-degree, interactive experience. , The ... ability to virtually experience the exhibit design Catalyst created ... and services. Users have the ability to interact with ...
Breaking Medicine News(10 mins):Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2
... claimed that they have developed a vaccine against two ... question can easily kill humans and could potentially be ... viruses is that Hendra virus emerged in 1994, killing ... in Brisbane. Thereafter the trainer of Vo Rogue, died ...
... study has now proved that acupuncture, even sham acupuncture may ... migraine//. A comparable level of treatment efficacy has been documented ... with respect to reduction in migraine days. ,More ... for the study. The study participants who had two to ...
... investigate the possibility of building the labs across the world ... to invest $1.9bn from various developed countries where the investigation ... ,Tony Blair while facing questions in the House of Commons ... insisted that precautions were adequate. He proposed to set up ...
... the University of California, Irvine (UCI) and also the ... drug// AF267B is effective against both forms of brain ... ,This compound (AF267B) curbs both the amyloid protein plaques ... lesion, the tangles of protein called tau. ...
... Cancer researcher Philippa Darbre, PhD, of the University of Reading ... the use of deodorants or antiperspirants and breast cancer. She ... mimics estrogen in the body.// ,"Lifetime exposure to ... to breast cancer," Darbre said. "If the aluminum salts in ...
... bewildered as about 3,000 people in the steel town were affected ... reported in a small group at a slum// cluster in Panposh ... Since then, it has rapidly spread to other parts of the ... and acute colic pain, said a senior district health official. ...
Cached Medicine News:Health News:Experimental Alzheimer’s Drug curbs the disease in mic 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: